Linked Life Data

19047254

Source:http://linkedlifedata.com/resource/pubmed/id/19047254

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-12-2
pubmed:abstractText
Hydroxyurea is the only approved medication for the treatment of sickle cell disease in adults; there are no approved drugs for children.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1098-4275
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
122
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1332-42
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.
pubmed:affiliation
Department of Pediatrics, Johns Hopkins University School of Medicine, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205, USA. jstrous1@jhmi.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review